Biotechnology Focus November 2012

Page 16

By: Shawn Lawrence

Genomics

tHE PRoMisE AND PoWER

oF GENoMics Ten years ago, the Gairdner Foundation brought together some of the world’s finest minds for a series of signature presentations examining what was then a comparatively young science: genomics.

That event, organized by Genome Canada and the Gairdner Foundation, was one of the first to put Canada in the genomics race. In the time since, advancements in the field both here and abroad have reached critical mass, so it seems fitting that the two sides have come together once again to put on another genomics extravaganza. The special two day conference will take place on Nov. 27 and 28 in Ottawa. Many of those same scientists that attended in 2002 will be back as well as a host of new superstar scientists. Billed as “The Power and Promise of Genomics,” this event not only marks 12 years of progress in the genomics field in Canada, but also the remarkable expansion of genomics research and its applications in sciences that stretch beyond human health. “Looking back 10 years later, I think genomic research has really transformed both biology and medicine,” says John Dirks, president and scientific director of the Gairdner Foundation and the individual mostly responsible for putting the original event together. For Dirks, the timing for such an event couldn’t be any better. “On the human health side, we’ve identified over 3,000 new monogenetic inherited diseases and many genome wide syndromes, such as type 2 diabetes and so on. Overall, a lot has happened in this field. Moreover not 16 BIOTECHNOLOGY FOCUS NOVEMBER 2012

enough attention has been given to genomics and its achievements since the Human Genome project, and this is partly why we approached Genome Canada to hold this milestone event once more.” Dirks adds that what sets this forum apart from its predecessor is that it not only brings together an impressive mix of genomics researchers and academics, but also includes end users, as well as public and private research agencies and funding organizations. Genome Canada president and CEO Pierre Meulien adds that much thought has gone into planning this once-in-a-decade forum, which includes a remarkable compilation of speakers spread amongst panels in all areas of the life sciences. “The first day is very much on the human

health piece, while the second day shines a light on all the activity going in biofuels, crops, livestock, food security, forestry and fisheries and so on,” he says. The reason for including these other sectors in the event program is simple, genomics has expanded into these other fields and is delivering results in the bioeconomy. “Genomics is evident in many areas of science and not just human health, but few people realize this. That’s really the goal here, to not only try and bring together those same people from the original event, but to also bring new players in that have taken the findings and the technology and applied it right across the spectrum,” says Meulien. While the advancements on the human health side are more known, Meulien stresses

“We weren’t able to bring back all our winners from 2002, but in order to deal with the topics we selected there likely wouldn’t have been room for them all. It’s almost the nature of the beast if you will. And having all these people together could lead to other great things, future collaborations and future successes.” — John Dirks


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.